Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Progenics Pharmaceuticals Company Profile (NASDAQ:PGNX)

Consensus Ratings for Progenics Pharmaceuticals (NASDAQ:PGNX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Progenics Pharmaceuticals (NASDAQ:PGNX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/8/2013Brean CapitalUpgradeHold -> Buy$9.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2012Brean CapitalDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/8/2012Lazard LtdDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
8/30/2012Stifel NicolausInitiated CoverageHoldViewTweet This Rating  Share This Rating on StockTwits
7/30/2012Needham & Company LLCDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)